Product Program year 2019 Source: CMS Open Payments

Gaucher-Disease

Drug

Open in the dashboard

General payments

$11,912

658 payments

Research payments

$198,281

78 payments

Through program year 2019, $11,912 in general payments and $198,281 in research payments were reported against Gaucher-Disease.

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2019 General $11,912 658
2019 Research $198,281 78

Breakdown

Who paid General payments · program year 2019
  1. Genzyme Corporation $11,745 655 payments
  2. Sanofi-Aventis U.S. LLC $168 3 payments
Top recipients General payments · program year 2019
  1. Idelfia Marte Medical Oncology · Clearwater, FL $86 <1% · 4 payments
  2. Joel Weinthal Pediatric Hematology-Oncology · Dallas, TX $85 <1% · 1 payment
  3. Hafeez Chatoor Medical Oncology · Tampa, FL $81 <1% · 4 payments
  4. Herbert Duvivier Hematology & Oncology · Cheektowaga, NY $74 <1% · 4 payments
  5. Miguel Pelayo Medical Oncology · Bradenton, FL $68 <1% · 3 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2019.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2019
  1. Hematology & Oncology Internal Medicine $3,342 29% · 168 practitioners
  2. Medical Oncology Internal Medicine $2,274 20% · 89 practitioners
  3. Internal Medicine $1,068 9% · 58 practitioners
  4. Pediatrics $625 5% · 31 practitioners
  5. Gastroenterology Internal Medicine $583 5% · 31 practitioners

The top 5 of 47 specialties; each share is of general payments naming this product to practitioners with a specialty in 2019. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2019
  1. Florida $2,248 19% · 85 recipients
  2. Oklahoma $889 7% · 46 recipients
  3. California $821 7% · 39 recipients
  4. Michigan $686 6% · 34 recipients
  5. Texas $682 6% · 35 recipients

The top 5 of 35 states; each share is of general payments naming this product in 2019 where a state was reported.

The top 25 states, free in the app

658 general · 78 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2019

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record